The Journal of Allergy and Clinical Immunology: In Practice
Volume 9, Issue 5, May 2021, Pages 2083-2086
Clinical CommunicationsCOVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
Cited by (0)
Conflicts of interest: M. Giannetti, C. Akin, and M. Castells receive funding from Blueprint Medicines. K. Hartmann received research funding from Euroimmun and lecture or consultancy fees from Allergopharma, ALK-Abello, Blueprint, Deciphera, Menarini, Novartis, and Takeda. The rest of the authors declare no conflicts of interest.
© 2021 American Academy of Allergy, Asthma & Immunology